[Impact of COVID-19 outbreak on urology surgical waiting lists and waiting lists prioritization strategies in the Post-COVID-19 era].
Impacto del brote de COVID-19 en las listas de espera de cirugía urológica y estrategias de priorización en la era post-COVID-19.
COVID-19
Coronavirus
SARS-CoV-2
Urology
Waiting list
Journal
Actas urologicas espanolas
ISSN: 2173-5786
Titre abrégé: Actas Urol Esp (Engl Ed)
Pays: Spain
ID NLM: 101771154
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
received:
02
09
2020
accepted:
03
11
2020
entrez:
21
5
2021
pubmed:
22
5
2021
medline:
4
6
2021
Statut:
ppublish
Résumé
The suspension of most elective surgeries during COVID-19 pandemic caused the lengthening of urology surgical waiting lists. The objective of this study is to evaluate the impact of COVID-19 pandemic on urology surgical waiting list in a high-volume hospital. An observational descriptive study was designed. All patients included in the urology surgical waiting list of our high-volume center on May 1 A total of 350 patients were included. The mean (SD) time on the waiting list was 97.33 (55.47) days. Priority 1 patients, who normally should undergo surgery within 30 days, were on the waiting list for a mean (SD) time of 60.51 (20.14) days. They were mainly patients with ureteral lithiasis (25.6%), high-risk or muscle-invasive bladder cancer (20.9%) and high-risk prostate cancer (13.9%). The mean waiting time had already significantly exceeded the mean time to surgery in 2019 for radical cystectomy (p = 0.04) and URS (p = 0.003). The suspension of most elective surgeries due to COVID-19 had a significant impact on urology surgical waiting list of our high-volume center, especially in priority 1 group.
Identifiants
pubmed: 34017152
doi: 10.1016/j.acuro.2020.11.001
pii: S0210-4806(20)30247-3
pmc: PMC7648495
doi:
Types de publication
Journal Article
Observational Study
Langues
spa
Pagination
207-214Informations de copyright
© 2021 AEU. Published by Elsevier España, S.L.U. All rights reserved.
Références
BJU Int. 2020 Aug;126(2):256-258
pubmed: 32406551
Eur Urol. 2020 Jun;77(6):663-666
pubmed: 32279903
J Am Coll Surg. 2020 Aug;231(2):281-288
pubmed: 32278725
Eur Urol Focus. 2021 May;7(3):659-661
pubmed: 32405544
Eur Urol. 2020 Jul;78(1):e38-e39
pubmed: 32192816
EClinicalMedicine. 2020 Apr 05;21:100331
pubmed: 32292899
Front Med (Lausanne). 2017 Sep 29;4:157
pubmed: 29034236
BJU Int. 2020 Aug;126(2):245-247
pubmed: 32407585
Int J Infect Dis. 2020 Feb;91:264-266
pubmed: 31953166
Eur Urol. 2020 Jul;78(1):21-28
pubmed: 32376137
Eur Urol. 2020 Jul;78(1):16-20
pubmed: 32362498
BJU Int. 2020 Jun;125(6):E7-E14
pubmed: 32249538
Eur Urol Oncol. 2019 Jul;2(4):390-396
pubmed: 31277775
Int J Surg. 2020 Apr;76:71-76
pubmed: 32112977
Eur Urol. 2020 Jul;78(1):29-42
pubmed: 32414626
Actas Urol Esp (Engl Ed). 2020 Sep;44(7):450-457
pubmed: 32456883
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
BJU Int. 2018 Jul;122(1):89-98
pubmed: 29569824
Minerva Urol Nefrol. 2020 Jun;72(3):369-375
pubmed: 32202401
Eur Urol Focus. 2020 Sep 15;6(5):1132-1134
pubmed: 32389498